Here’s a roundup of companies announcing new distribution deals.
- Varian lands $450 million Toshiba contract
Varian Medical Systems Inc. (NYSE:VAR) announced the execution of a three year, approximately $450 million contract for Varian to supply medical imaging subcomponents to Toshiba Medical Systems for integration into diagnostic imaging equipment for the global market. Orders will be booked over the period of the agreement.
- BioMedix Now Exclusive Industry Distributor of the APMA Coding Resource Center
BioMedix has announced that it initiated an exclusive partnership with the American Podiatric Medical Association (APMA) to become the sole distributor of the APMA Coding Resource Center (CRC) online coding and reimbursement resource which includes foot, ankle and leg-relevant CPT, ICD-9 and HCPCS Level II codes that can be fully integrated with BioMedix TRAKnet DPM Practice Management Solutions. This exciting partnership provides the most accessible and cost-effective coding information for podiatric practices.
- Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR and DEFINITY
Lantheus Medical Imaging Inc., a worldwide leader in diagnostic medical imaging, announced a national contract with Novation for ABLAVAR (gadofosveset trisodium) and DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension, providing increased access to these important diagnostic imaging agents for health care providers served by Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
- Intelligent Medical Devices Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests
IMDx (privately held) announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.
- Milestone Scientific Signs Agreement with Towncare Dental Partnership Inc. for Its STA Single Tooth Anesthesia Instruments
Milestone Scientific Inc. (OTC:MLSS), the recognized leader in advanced, computer-controlled injection technologies, has signed an agreement, through a distributor, to provide Towncare Dental Partnership Inc. with STA Single Tooth Anesthesia System instruments. The agreement covers all of Towncare’s dental offices in Florida. The instruments will be rolled out to Towncare’s offices over the next four months, and Milestone will provide training and support to each office.
- WellAWARE Systems to Offer Philips Lifeline Medical Alert Service as Part of Their Health Monitoring Solution for Seniors
WellAWARE Systems, a leading developer of next-generation, activity-based wellness monitoring solutions for senior care providers, announced it has entered into a co-marketing agreement with Philips Lifeline. Philips Lifeline is the leading provider of medical alert services in North America, monitoring more than 700,000 subscribers. The companies will collaborate to deliver their unique monitoring solutions into the home for the benefit of resident seniors.
- Neuro-Biotech Pursues the Implementation of its Licensees Network and Signs a LOI with Israel
Neuro-Biotech Corp. (MRES-OTSQB) is pleased to announce the signing of a Letter of Intent with a major distributor in Israel. Both groups are discussing the details of a Licensing Agreement based on similar terms and conditions as the recently negotiated agreement with the Russian company Credo-TM.
- BioClinica Partners with Symbiance
BioClinica® Inc., (NSDQ:BIOC), a global provider of clinical trial management solutions, announced it has established a strategic partnership with Symbiance Inc., a specialty contract research organization (CRO) based in Princeton Junction, New Jersey. Symbiance concentrates in therapeutic areas relevant to pharmaceutical and biotechnology companies with particular focus in oncology and CNS.
- Covidien Announces the Integration of its Nellcor OxiMax Platform into the Welch Allyn Connex Vital Signs Monitor
Covidien plc (NYSE:COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, announced the integration of its Nellcor OxiMax platform with SatSeconds technology into the Welch Allyn Connex Vital Signs Monitor (VSM ). The same OxiMax technology is featured in the Nellcor OxiMax N-600x pulse oximeter, the Company’s full-featured flagship oximeter that delivers accurate, reliable readings even during low perfusion and signal interference.